Schonfeld Strategic Advisors LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,660,948
-7.1%
79,700
+6.7%
0.01%
-13.3%
Q2 2023$1,788,274
+117.8%
74,667
+120.3%
0.02%
+114.3%
Q1 2022$821,000
+48.7%
33,900
+2.1%
0.01%
+16.7%
Q3 2021$552,000
-52.5%
33,200
-30.4%
0.01%
-50.0%
Q2 2021$1,162,000
+192.7%
47,673
+209.5%
0.01%
+140.0%
Q1 2021$397,000
-75.7%
15,402
-61.1%
0.01%
-83.9%
Q3 2020$1,635,000
-26.5%
39,629
-13.7%
0.03%
+3.3%
Q2 2020$2,224,000
+939.3%
45,906
+815.0%
0.03%
+500.0%
Q4 2019$214,000
-97.3%
5,017
-98.3%
0.01%
-98.2%
Q2 2019$7,947,000
+211.5%
297,300
+212.9%
0.28%
+215.7%
Q1 2019$2,551,000
+92.4%
95,000
+15.9%
0.09%
+74.5%
Q4 2018$1,326,000
-37.9%
82,000
-20.3%
0.05%
-46.3%
Q3 2018$2,136,000
+469.6%
102,900
+320.0%
0.10%
+375.0%
Q2 2018$375,000
-83.8%
24,500
-76.3%
0.02%
-88.5%
Q1 2018$2,318,000
+198.3%
103,161
+282.9%
0.17%
+72.3%
Q4 2016$777,000
-33.5%
26,944
-26.7%
0.10%
-49.2%
Q3 2016$1,169,000
-12.1%
36,758
-10.3%
0.20%
-33.2%
Q2 2016$1,330,000
+25.8%
40,968
+8.4%
0.30%
-30.9%
Q1 2016$1,057,00037,7960.43%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders